These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8384126)

  • 41. Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.
    Shi YE; Torri J; Yieh L; Wellstein A; Lippman ME; Dickson RB
    Cancer Res; 1993 Mar; 53(6):1409-15. PubMed ID: 8383010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines.
    Meikle MC; Bord S; Hembry RM; Compston J; Croucher PI; Reynolds JJ
    J Cell Sci; 1992 Dec; 103 ( Pt 4)():1093-9. PubMed ID: 1336777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
    Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
    Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin).
    Mast AE; Enghild JJ; Nagase H; Suzuki K; Pizzo SV; Salvesen G
    J Biol Chem; 1991 Aug; 266(24):15810-6. PubMed ID: 1651920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin.
    Varani J; Hattori Y; Chi Y; Schmidt T; Perone P; Zeigler ME; Fader DJ; Johnson TM
    Br J Cancer; 2000 Feb; 82(3):657-65. PubMed ID: 10682680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis.
    McLaughlin B; Weiss JB
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):739-45. PubMed ID: 8760357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions.
    Tjäderhane L; Larjava H; Sorsa T; Uitto VJ; Larmas M; Salo T
    J Dent Res; 1998 Aug; 77(8):1622-9. PubMed ID: 9719036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells.
    Yasumitsu H; Miyazaki K; Umenishi F; Koshikawa N; Umeda M
    J Biochem; 1992 Jan; 111(1):74-80. PubMed ID: 1318881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.
    Kawashima A; Nakanishi I; Tsuchiya H; Roessner A; Obata K; Okada Y
    Virchows Arch; 1994; 424(5):547-52. PubMed ID: 8032535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
    Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis.
    Delacourt C; Le Bourgeois M; D'Ortho MP; Doit C; Scheinmann P; Navarro J; Harf A; Hartmann DJ; Lafuma C
    Am J Respir Crit Care Med; 1995 Aug; 152(2):765-74. PubMed ID: 7633740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
    J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates.
    Bigg HF; Clark IM; Cawston TE
    Biochim Biophys Acta; 1994 Sep; 1208(1):157-65. PubMed ID: 8086430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Degradation of the COL1 domain of type XIV collagen by 92-kDa gelatinase.
    Sires UI; Dublet B; Aubert-Foucher E; van der Rest M; Welgus HG
    J Biol Chem; 1995 Jan; 270(3):1062-7. PubMed ID: 7836360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.
    Collier IE; Wilhelm SM; Eisen AZ; Marmer BL; Grant GA; Seltzer JL; Kronberger A; He CS; Bauer EA; Goldberg GI
    J Biol Chem; 1988 May; 263(14):6579-87. PubMed ID: 2834383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.